Home > Insider Trading > Filing (0001209191-15-055608)

Filing Details

Accession Number:: 0001209191-15-055608
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-23 12:33:45
Reporting Period:: 2015-06-19

Filing Date:: 2015-06-23
Accepted Time:: 2015-06-23 12:33:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1121702	Metabolix Inc.	MBLX	Miscellaneous Plastics Products (3080)	043158289

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1603544	Birchview Fund Llc	688 Pine Street, Suite D Burlington VT 05401	Yes	No	No	No
1618112	Birchview Partners, Llc	688 Pine Street, Suite D Burlington VT 05401	Yes	No	No	No
1618205	Birchview Capital, Lp	688 Pine Street, Suite D Burlington VT 05401	Yes	No	No	No
1618206	Birchview Capital Gp, Llc	688 Pine Street, Suite D Burlington VT 05401	Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-19	43,700	$3.32	710,366	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants	Acquisiton	2015-06-19	39,330	$0.13	39,330	$3.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,330	2015-06-19	2019-06-19	No	4	P	Indirect

Footnotes

The reported securities are included within 43,700 units of Issuer securities (the "Units") purchased by Birchview Fund, LLC (the "Fund") for $3.4325 per Unit pursuant to a Securities Purchase Agreement, dated June 15, 2015 by and among the Issuer, the Fund and certain other qualified institutional and individual investors. Each Unit consists of one share of of the Issuer's Common Stock, par value $0.01 per share ("Common Stock") and and nine-tenths of a Common Stock warrant to purchase one share of Common Stock at an exercise price of $3.98 per share (subject to adjustment in the event of stock splits, stock dividends, reclassifications and the like) (the "Warrant").
The shares of Common Stock reported herein give effect to the 1-for-6 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 26, 2015.
Birchview Partners, LLC (the "Manager") is a member of Birchview Capital GP, LLC (the "GP"), which is the general partner of Birchview Capital, LP (the "Investment Manager"), the investment Manager of the Fund. The Manager disclaims Section 16 beneficial ownership of the shares of Common Stock, the Warrant and the shares of Common Stock underlying the Warrant, held by the Fund (collectively, the "Fund Securities") and this report shall not be deemed an admission that such reporting person is the beneficial owner of such Fund Securities, except to the extent of its pecuniary interest, if any, in the Fund Securities by virtue of its membership interest in the Fund.
(Continued from Footnote 3) The GP and Investment Manager disclaim Section 16 beneficial ownership of the Fund Securities and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such Fund Securities, except to the extent of their pecuniary interest, if any, in the Fund Securities by virtue of their management fee interest in the Fund.
Matthew Strobeck, the sole member of the GP, serves as the representative of the GP, the Investment Manager and the Fund on the Issuer's board of directors.